First, insulin resistance promotes neuroinflammation, characterized by chronic low‐grade inflammatory responses, elevating pro‐inflammatory cytokines (such as interleukin‐6 [IL‐6] and tumor necrosis factor alpha [TNF‐α]), which impair neuroplasticity and enhance neuronal vulnerability (Leonard and Wegener 2020). The gene discussed is IL6; the disease is Insulin resistance.